NCT03661411View on ClinicalTrials.gov

Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

760

Participants

Timeline

Start Date

October 17, 2018

Primary Completion Date

July 18, 2022

Study Completion Date

July 18, 2022

Conditions
Stroke
Interventions
DRUG

Aspirin

100mg qd

DRUG

Clopidogrel 75mg

75mg（after first dose of 300mg）qd

DRUG

Alteplase

Iv at 0.9 milligrams per kilogram (mg/kg)

Trial Locations (1)

Unknown

Lin Tao, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER

NCT03661411 - Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke | Biotech Hunter | Biotech Hunter